CHRSNasdaq

Coherus Oncology, Inc.

Biological Products, (No Diagnostic Substances) · DE · CIK 1512762

Develops and commercializes innovative immuno-oncology medicines, including LOQTORZI, for various cancers

red 8-K · 90d

$216M

Market cap

$1.40

Last close

-3.5%

-4.1%

665K

Volume

Price · last 40 sessions-19.1%

May 4L $1.36 · H $1.95Jun 30

335

Total filings

Jun 15, 2026

Last filing

12/31

Fiscal year end

Similar companies

Comparable business profile · signals at a glance